WallStreetZen

AnalystsZegbeh Jallah
Zegbeh Jallah's Stock Forecasts

Analyst Ranking
Top 3%
#100 out of 3474 analysts
Average Return
+142.82%
Win Rate
47%8 out of 17
Risk vs Reward
Poor
Good

Zegbeh Jallah's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ocugen IncOCGN
+2,086.21%$0.29$6.34
2020-11-16 -
2021-06-11
Strong Buy
IDEAYA Biosciences IncIDYA
+469.48%$4.03$22.95
2020-03-12 -
2021-03-12
Strong Buy
aTYR PHARMA INCLIFE
+40.72%$6.14$8.64
2021-03-15 -
2021-10-27
Strong Buy
Kodiak Sciences IncKOD
+36.96%$81.70$111.90
2021-05-10 -
2021-10-27
Strong Buy
Inventiva SAIVA
+21.37%$10.67$12.95
2020-08-04 -
2021-08-04
Strong Buy

Zegbeh Jallah's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Syros Pharmaceuticals IncSYRS
1Strong Buy$23.00+465.11%Maintains
a month ago
aTYR PHARMA INCLIFE
2Strong Buy$21.00+143.06%Maintains
a month ago
Rezolute IncRZLT
1Strong Buy$21.00+223.08%Initiates Coverage On
2 months ago
Arvinas IncARVN
1Strong Buy$135.00+62.51%Maintains
3 months ago
Dare Bioscience IncDARE
1Strong Buy$11.00+638.26%Maintains
4 months ago
Ocugen IncOCGN
2Hold$6.00-37.57%Downgrades
5 months ago
Kodiak Sciences IncKOD
2Strong Buy$149.00+33.15%Upgrades
6 months ago
KalVista Pharmaceuticals IncKALV
1Strong Buy$55.00+234.55%Maintains
8 months ago
Applied Genetic Technologies CorpAGTC
2Strong Buy$35.00+1,256.59%Maintains
9 months ago
Enanta Pharmaceuticals IncENTA
1Strong Buy$104.00N/AReinstates
a year ago
Inventiva SAIVA
1Strong BuyN/AN/AInitiates Coverage On
a year ago
Clearside Biomedical IncCLSD
1Strong Buy$8.00N/AInitiates Coverage On
a year ago
RAPT Therapeutics IncRAPT
1Strong Buy$38.00N/AInitiates Coverage On
2 years ago
IDEAYA Biosciences IncIDYA
1Strong Buy$12.00N/AInitiates Coverage On
2 years ago
X4 Pharmaceuticals IncXFOR
1Strong Buy$20.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.